JACLYN CALLAHAN: Open Payments
NPI 1558793125 · ROGERS, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$606 in 30 payments from 10 companies in 2025. Trend: 2023 $721 · 2024 $724 · 2025 $606
Food & beverage: $606
| Company | Payments | Amount |
|---|---|---|
| Exeltis, USA Inc. | 11 | $190 |
| MILLICENT US INC | 4 | $89 |
| Hologic Sales and Service, LLC | 3 | $76 |
| Organon LLC | 2 | $55 |
| Biogen, Inc. | 3 | $52 |
| Alexion Pharmaceuticals, Inc. | 1 | $35 |
| Sumitomo Pharma America, Inc. | 2 | $34 |
| Averitas Pharma Inc. | 2 | $32 |
| LSI SOLUTIONS INC | 1 | $22 |
| Astellas Pharma US Inc | 1 | $20 |
Products named: SLYND, NEXPLANON, ZURZUVAE, INTRAROSA, FEMLYV, ACESSA PROVU SYSTEM, ULTOMIRIS, MYFEMBREE.
Industry payments across AR — which companies pay providers there.
